eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | retinal vein occlusion |
| Comorbidity | C0271051|macular edema |
| Sentences | 176 |
| PubMedID- 25902116 | Patients and methods: a case series of treatment naive patients followed in the jules gonin eye hospital for macular edema due to central retinal vein occlusion is presented. |
| PubMedID- 21911591 | Evaluation of macular function using focal macular electroretinography in eyes with macular edema associated with branch retinal vein occlusion. |
| PubMedID- 25902119 | Patients and methods: we describe a retrospective series of patients followed in the medical retina unit of the jules gonin eye hospital for macular edema due to ischemic central retinal vein occlusion, refractory to monthly retreatment with ranibizumab, and changed to aflibercept. |
| PubMedID- 26454243 | Microvascular abnormalities on optical coherence tomography angiography in macular edema associated with branch retinal vein occlusion. |
| PubMedID- 23510041 | Background and objective: to evaluate the influence of serous retinal detachment (srd) on the outcome of pars plana vitrectomy (ppv) for macular edema in patients with branch retinal vein occlusion (brvo). |
| PubMedID- 20681253 | [pathogenesis of macular edema associated with branch retinal vein occlusion and strategy for treatment]. |
| PubMedID- 21598607 | [medium-term effects of intravitreal bevacizumab for macular edema associated with central retinal vein occlusion]. |
| PubMedID- 24741610 | It was approved by the fda for the treatment of neovascular amd, macular edema associated with retinal vein occlusion, and since 2012, it is approved for the treatment of dme [23]. |
| PubMedID- 20827142 | Purpose: the purpose of this study was to evaluate the effect of intravitreal triamcinolone acetonide on macular function in cases of macular edema because of central retinal vein occlusion. |
| PubMedID- 25885285 | Background: dexamethasone intravitreal implant (dex implant) is a sustained-release biodegradable implant approved for treatment of macular edema associated with retinal vein occlusion (rvo). |
| PubMedID- 22392532 | It is an fda-approved intravitreal therapy for the treatment of age-related macular degeneration [70] and macular edema associated with retinal vein occlusion [71]. |
| PubMedID- 21191716 | Purpose: to study prognostic factors for visual acuity (va) after intravitreal bevacizumab injection (ivb) for macular edema (me) associated with retinal vein occlusion (rvo), by evaluating the correlation between the final va and va at baseline and at 1, 3, and 6 months after the initial ivb. |
| PubMedID- 25576994 | Purpose: to review the available evidence regarding the safety and efficacy of therapies for the treatment of macular edema (me) associated with central retinal vein occlusion (crvo). |
| PubMedID- 20801424 | Purpose: to investigate the effects of an intravitreal injection of autologous plasmin enzyme for macular edema associated with a branch retinal vein occlusion (brvo). |
| PubMedID- 22246387 | Treatment of macular edema due to branch retinal vein occlusion with single or multiple intravitreal injections of bevacizumab. |
| PubMedID- 22988344 | Ozurdex received fda approval in june 2009 for the treatment of macular edema associated with retinal vein occlusion, and in september 2010, it became the second fda-approved therapeutic agent for the treatment of noninfectious posterior uveitis. |
| PubMedID- 24104718 | We report three patients of retinal vein occlusion with macular edema who demonstrated overnight resolution of macular edema following treatment with intravitreal ranibizumab (0.5 mg). |
| PubMedID- 23972086 | Purpose/aim: the aqueous humor level of soluble vascular endothelial growth factor receptor (svegfr)-2 may influence macular edema in patients with branch retinal vein occlusion (brvo). |
| PubMedID- 20858114 | Purpose: to compare the efficacy of intravitreal injection of triamcinolone, bevacizumab, and a combination of triamcinolone-bevacizumab for the management of macular edema due to branch retinal vein occlusion. |
| PubMedID- 25390716 | Conclusion: ozurdex may be effective in reducing macular edema because of a branch retinal vein occlusion in eyes refractory to multiple other treatments. |
| PubMedID- 25820576 | The purpose of this study is to evaluate the long-term visual, anatomical and electrophysiological outcomes of repeated intravitreal injections of bevacizumab for macular edema due to retinal vein occlusion (rvo) and investigate any possible toxic effects on the central fovea. |
| PubMedID- 24528934 | Purpose: to test a combination of dexamethasone intravitreal implant with macular grid laser for macular edema in patients with branch retinal vein occlusion (brvo). |
| PubMedID- 22527327 | Background: the purpose of this study was to compare the efficacy of intravitreal ranibizumab in the treatment of macular edema due to branch retinal vein occlusions (brvo) with and without serous macular neuroretinal detachment (smd). |
| PubMedID- 23044946 | Management of macular edema associated with retinal vein occlusion. |
| PubMedID- 24330936 | There is an urgent requirement to find effective therapeutic procedures for the treatment of refractory eye diseases of posterior segment such as posterior uveitis, proliferative vitreoretinopathy, and macular edema associated with diabetes and retinal vein occlusion. |
| PubMedID- 21750607 | Purpose: to present the functional and anatomic changes after intravitreal bevacizumab in eyes with macular edema (me) due to branch retinal vein occlusion (brvo). |
| PubMedID- 23650454 | The aim of the present review is to summarize the clinical evidence of ranibizumab for macular edema due to retinal vein occlusions. |
| PubMedID- 21386915 | In agreement with this hypothesis, we previously found that the vitreous level of vegf was lower at the time of repeat vitrectomy than at the initial operation in patients with macular edema due to retinal vein occlusion,33 and it was also reported that ppv prevents retinal hypoxia in patients with brvo.34 we recently demonstrated that the vitreous fluid level of pedf has a significant negative correlation with the nonperfused area of the retina.3 accordingly, expression of pedf may be upregulated to prevent retinal hypoxia after ppv, and this may be another mechanism by which ppv improves macular edema in brvo patients. |
| PubMedID- 22304619 | Functional-morphological changes after intravitreal injection of triamcinolone acetonide for macular edema with branch retinal vein occlusion. |
| PubMedID- 20417567 | Objective: to evaluate the safety and efficacy of dexamethasone intravitreal implant (dex implant; ozurdex, allergan, inc., irvine, ca) compared with sham in eyes with vision loss due to macular edema (me) associated with branch retinal vein occlusion (brvo) or central retinal vein occlusion (crvo). |
| PubMedID- 20935688 | Visual improvement in established central retinal vein occlusion with long-standing macular edema following systemic eculizumab treatment. |
| PubMedID- 24191132 | When the device was implanted in patients with macular edema due to retinal vein occlusion in the geneva study, similar improvements in visual acuity were found. |
| PubMedID- 20531142 | Conclusion: individualized repeated intravitreal injections of ranibizumab showed promising short-term results in visual acuity improvement and decrease in cft in patients with macular edema associated with branch retinal vein occlusion. |
| PubMedID- 26150834 | Methods: forty six eyes of 45 patients who were administered intravitreal ranibizumab because of macular edema due to retinal vein occlusion (rvo) were included in this retrospective clinical study. |
| PubMedID- 22080912 | Changes in visual acuity and foveal photoreceptor integrity in eyes with chronic cystoid macular edema associated with retinal vein occlusion. |
| PubMedID- 24439442 | Purpose: to determine whether a significant correlation exists between the presence of a bulge in the photoreceptor inner segment/outer segment (is/os) line and the best-corrected visual acuity (bcva) in eyes with resolved macular edema associated with branch retinal vein occlusion (brvo). |
| PubMedID- 23006995 | Purpose: to evaluate the effects of repeated intravitreal dexamethasone implant (idi) (ozurdex(r)) in eyes with macular edema (me) due to retinal vein occlusion (rvo). |
| PubMedID- 23629790 | Background: the efficacy of a single dose of ozurdex(r) was evaluated over a 6-month period in eyes with macular edema due to retinal vein occlusion and intraocular inflammatory disease. |
| PubMedID- 23225839 | Methods: eighty-nine eyes with macular edema associated with retinal vein occlusion first received periocular injection of 40 mg triamcinolone acetonide (ta) and were followed for one month. |
| PubMedID- 25371814 | Long-term outcome after vitrectomy for macular edema with retinal vein occlusion dividing into the occlusion site. |
| PubMedID- 24634869 | Aim: to compare the efficacy of ranibizumab and bevacizumab for macular edema due to retinal vein occlusion (rvo). |
| PubMedID- 21538003 | Vitreous inflammatory factors in macular edema with central retinal vein occlusion. |
| PubMedID- 25705695 | To compare the efficacy of different therapies in the treatment of macular edema associated with retinal vein occlusion (rvo). |
| PubMedID- 25644536 | Purpose: to determine whether the highly reflective vertical lines seen in spectral-domain optical coherence tomographic (sd oct) images, which we have termed track lines, after resolution of macular edema associated with branch retinal vein occlusion are related to the integrity of the photoreceptors. |
| PubMedID- 22739239 | Purpose: to compare the efficacy and safety of three intravitreal bevacizumab upload injections followed by a dexamethasone implant versus dexamethasone implant monotherapy in eyes with macular edema due to retinal vein occlusion. |
| PubMedID- 21150231 | Purpose: my aim was to evaluate the effect of intravitreal bevacizumab and to determine the concentrations of inflammatory cytokines in patients with macular edema due to branch retinal vein occlusion (brvo), according to the site of the occlusion. |
| PubMedID- 21337042 | Background: to identify predictive factors for improvement of visual acuity and central retinal thickness by intravitreal bevacizumab for the treatment of macular edema (me) due to branch retinal vein occlusion (brvo). |
| PubMedID- 24847256 | We report a 19-year-old patient who developed a central retinal vein occlusion (crvo) with significant macular edema and visual impairment following intense exercise and dehydration. |
| PubMedID- 26366053 | Comparative analysis of the development of collateral vessels in macular edema due to branch retinal vein occlusion following grid laser or ranibizumab treatment. |
| PubMedID- 23539479 | The influence of retinal ischemia on changes of visual acuity, macular sensitivity, macular thickness, and macular volume is unclear after pars plana vitrectomy (ppv) for macular edema with branch retinal vein occlusion (brvo). |